Parsa Kiai bought $9K of Medifast stock
By AlphaYouPublished Form 4
Kiai Parsa
Reporting filer
Parsa Kiai reported buying 661 shares of Medifast Inc for about $9K ($13.03 a share on average). Form 4 filed Nov 6, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Kiai Parsa | 2026-11-04 | P | Purchase | 661 | 13.0255 | 21,089 | 2 days | Filed terms
|
Common Stock
- Owner
- Kiai Parsa
- Date
- 2026-11-04
- Code
- P
- Action
- Purchase
- Quantity
- 661
- Price
- 13.0255
- Following holdings
- 21,089
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-04
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 661
- transaction Price Per Share: 13.0255
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 21089
- direct Or Indirect Ownership: I
- nature Of Ownership: Notes
- id: F1
- id: F2
- id: F3
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Kiai Parsa: Director.
- F1: Ownership of Steamboat Capital Partners II, LP (II).
- F2: Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from II. Parsa Kiai ("Kiai") is the Managing Member of GP. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
- F3: This is an average price. Actual prices paid for the shares purchased on 11/04/26 and reported on this line range from $12.87 to $13.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Original sources
Prepared automatically from public filing data. Report a correction.